Status:
COMPLETED
UltraMTP in Adult Trauma Patients Undergoing Surgery Within 24 Hours: Effects on Mortality and Clinical Outcomes
Lead Sponsor:
University of Southern California
Collaborating Sponsors:
University of California, Irvine
University of California, Davis
Conditions:
Trauma
Blood Transfusion Complication
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this study is to determine the effects of ultraMTP (\>/=30 units pRBC within 24 hours) in trauma patients on mortality and secondary outcomes. The aim is to determine if there is a set ...
Detailed Description
Rationale: To determine if there is a set number of pRBC units transfused in adult trauma patients undergoing surgery within 24 hours, after which mortality is inevitable and further transfusions are ...
Eligibility Criteria
Inclusion
- \>/= 18 years old
- trauma patient
- undergoing surgery within first 24 hours of admission
- received blood products within 24 hours of admission
Exclusion
- \<18-years-old
- no surgery within the first 24 hours
- did not receive blood products within the first 24 hours
Key Trial Info
Start Date :
August 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
3000 Patients enrolled
Trial Details
Trial ID
NCT04866953
Start Date
August 15 2021
End Date
December 31 2023
Last Update
March 5 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Keck School of Medicine of the University of Southern California
Los Angeles, California, United States, 90033